Strong Capital StructureA high equity ratio and modest debt-to-equity demonstrate conservative capitalization and financial flexibility. Sustained ROE near 14% shows efficient use of shareholder capital, supporting long-term investment, R&D funding and resilience to cyclical stress without heavy leverage.

Durable Profit MarginsRobust gross and operating margins indicate structural cost advantages or pricing power. High EBITDA and EBIT margins provide long-run operating cash buffer, enabling reinvestment and protecting profitability through cycles, supporting sustainable free cash generation potential.

Improving Cash Generation TrendsOperating cash conversion above 1x and positive free cash flow growth show improving cash dynamics. Steady operating cash conversion supports capital allocation flexibility and deleveraging over time, increasing the firm's ability to fund capex, dividends or strategic initiatives.

Bears Say

Weak Free Cash Flow LevelVery low FCF relative to net income signals limited residual cash after operations and investments. Persistent low conversion constrains shareholder returns and self‑funding capacity, potentially forcing external financing for growth or exposing the firm to liquidity stress under downturns.

Earnings Per Share DeclineA sharp EPS decline indicates income volatility or one-time hits affecting shareholder returns. If sustained, falling EPS erodes reinvestment capacity, weakens investor confidence, and may reflect margin, demand or operational challenges that impair long-term growth prospects.

Operational Profitability VolatilitySignificant EBIT volatility reduces predictability of cash flows and complicates planning for R&D, manufacturing or commercial expansion. Persistent swings may reflect cyclical exposure or inconsistent cost control, increasing execution risk for strategic initiatives over months to years.

177A FAQ

What was Kohjin Bio Co.,Ltd.’s price range in the past 12 months?

Kohjin Bio Co.,Ltd. lowest stock price was ¥1161.00 and its highest was ¥2020.00 in the past 12 months.

What is Kohjin Bio Co.,Ltd.’s market cap?

Kohjin Bio Co.,Ltd.’s market cap is ¥6.10B.

When is Kohjin Bio Co.,Ltd.’s upcoming earnings report date?

Kohjin Bio Co.,Ltd.’s upcoming earnings report date is May 20, 2026 which is in 86 days.

How were Kohjin Bio Co.,Ltd.’s earnings last quarter?

Kohjin Bio Co.,Ltd. released its earnings results on Feb 13, 2026. The company reported ¥15.18 earnings per share for the quarter, beating the consensus estimate of N/A by ¥15.18.

Is Kohjin Bio Co.,Ltd. overvalued?

According to Wall Street analysts Kohjin Bio Co.,Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Kohjin Bio Co.,Ltd. pay dividends?

Kohjin Bio Co.,Ltd. pays a Notavailable dividend of ¥24 which represents an annual dividend yield of 1.62%. See more information on Kohjin Bio Co.,Ltd. dividends here

What is Kohjin Bio Co.,Ltd.’s EPS estimate?

Kohjin Bio Co.,Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Kohjin Bio Co.,Ltd. have?

Kohjin Bio Co.,Ltd. has 5,111,600 shares outstanding.

What happened to Kohjin Bio Co.,Ltd.’s price movement after its last earnings report?

Kohjin Bio Co.,Ltd. reported an EPS of ¥15.18 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.548%.

Which hedge fund is a major shareholder of Kohjin Bio Co.,Ltd.?

Currently, no hedge funds are holding shares in JP:177A

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Kohjin Bio Co.,Ltd.

Kohjin Bio Co., Ltd. is a biotechnology company specializing in the development and production of bioactive compounds and fermentation products. The company operates primarily in the health and wellness sectors, focusing on nutritional supplements, functional foods, and pharmaceutical intermediates. Kohjin Bio is known for its innovative approaches to biotechnology, leveraging fermentation technology to create high-quality, bioavailable ingredients that cater to a growing market for health-conscious consumers.